Investing.com - Champions Oncology (NASDAQ: CSBR) reported third quarter EPS of $-0.160, $0.10 worse than the analyst estimate of $-0.060. Revenue for the quarter came in at $12M versus the consensus estimate of $13.5M.
Champions Oncology's stock price closed at $5.670. It is up 22.990% in the last 3 months and up 27.700% in the last 12 months.
Champions Oncology saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Champions Oncology's stock price’s past reactions to earnings here.
According to InvestingPro, Champions Oncology's Financial Health score is "fair performance".
Check out Champions Oncology's recent earnings performance, and Champions Oncology's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar